The Patent Finder
EO

Endo Operations Limited

First filing 2003
OverviewNotableFeesChangesFamiliesPatent listSources & methods

35 patents currently held

46 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jun 2027. from the record

Of the 46 now held by other companies, 37 name PH Health Limited as their current owner, and 9 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
23
Ending by 2030
Jun 2027
Next term end
21
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Formerly held, still cited

Notable
Cited by 100 later US patents, top 10% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029. A terminal disclaimer caps this term to an earlier patent's.
Ends Dec 2029 · High confidence
Also notable
Cited by 68 later US patents, top 10% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029. A terminal disclaimer caps this term to an earlier patent's.
Ends Dec 2029 · High confidence
Also notable
Cited by 25 later US patents, top 25% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2035. A terminal disclaimer caps this term to an earlier patent's.
now held by PH Health Limited
Ends Jan 2035 · Low confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jan 7 to 28, 2027 · next Jan 7
  • 1 fee due Mar 1, 2027
    The maintenance fee for Implant Device Release Agents and Methods of Using Same (US 9,120,249) comes due Mar 1, 2027. Unpaid by Sep 1, 2027, it lapses early.
  • 1 fee due Apr 6, 2027
    The maintenance fee for Apparatus and Method for Repairing Vaginal Reconstruction (US 9,149,351) comes due Apr 6, 2027. Unpaid by Oct 6, 2027, it lapses early.
  • 2 fees due May 14 to 17, 2027 · next May 14

Which patents, and when each one lapses · Pro

Recent changes

  • 10 terms have ended since Aug 17, 2026

What they patent

The 5 largest of its 21 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 7,553,863Ultrapure 4-Methylpyrazole
In force
 · High confidence
In forceHigh confidence
US 8,808,737Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
In force
 · High confidence
In forceHigh confidence
US 9,789,103Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
In force
 · High confidence
In forceHigh confidence
US 11,389,443Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
In force
 · High confidence
In forceHigh confidence
US 9,186,374Vitamin B12 Nasal Spray and Method of Use
In force
 · Medium confidence
In forceMedium confidence
US 7,722,527Surgical Implants and Related Methods
In force
 · High confidence
In forceHigh confidence
US 7,901,346Method for Supporting Vaginal Cuff
In force
 · High confidence
In forceHigh confidence
US 8,394,812Sustained Release Formulations of Nalbuphine
In force
 · High confidence
In forceHigh confidence
US 8,771,732Sustained release formulations of nalbuphine
In force
 · High confidence
In forceHigh confidence
US 9,090,649Oligonucleotide Duplexes Comprising DNA-Like and RNA-Like Nucleotides and Uses Thereof
In force
 · High confidence
In forceHigh confidence
10 of 35 patents shown.
Pro members see all 35.
Pro members: see all 35 patents
Also on record, not counted in the 35: 46 patents in force now held by others · 61 patents ended · 20 applications pending · 13 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited